Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

anti-cancer drug

  • You have access
    Phloretin Inhibits the Proliferation of Breast Cancer Cells Through the Down-regulation of Estrogen Receptor α
    SOON YOUNG JANG, JIYUN KIM, EUNBI HONG, YOON JUNG YANG, YURAN NA, CHANG-HWAN YEOM and SEYEON PARK
    Anticancer Research March 2024, 44 (3) 1109-1120; DOI: https://doi.org/10.21873/anticanres.16906
  • You have access
    Orally Administrated Glutamate Restored EAAT1 and 3 Expression Levels Suppressed in 5-Fluorouracil-damaged Intestinal Epithelial Cells
    SHIZUKA JONAN, MAI HANEDA and KIKUKO AMAGASE
    Anticancer Research March 2024, 44 (3) 1143-1147; DOI: https://doi.org/10.21873/anticanres.16909
  • You have access
    Integrin as a Molecular Target for Anti-cancer Approaches in Lung Cancer
    NITHIKOON AKSORN and PITHI CHANVORACHOTE
    Anticancer Research February 2019, 39 (2) 541-548; DOI: https://doi.org/10.21873/anticanres.13146
  • You have access
    Different Response Profiles of Gastrointestinal Cancer Cells to an L-Type Amino Acid Transporter Inhibitor, JPH203
    YASUHIDE MUTO, TOMOMI FURIHATA, MEIKA KANEKO, KOSUKE HIGUCHI, KENTARO OKUNUSHI, HANAE MORIO, YOSHIE REIEN, MASAYA UESATO, HISAHIRO MATSUBARA and NAOHIKO ANZAI
    Anticancer Research January 2019, 39 (1) 159-165; DOI: https://doi.org/10.21873/anticanres.13092
  • You have access
    Systematic Trial for Evaluating Docetaxel in a Human Prostate Cancer Cell DU145 Xenograft Model
    MIYUKI MABUCHI, MASAHIRO UEDA, YURI YOSHIDA, KOTA HORIIKE, KENTA YAMAOKA, SYUHEI NAKAO, TADASHI SHIMIZU, YUKO UEDA, KAZUTAKE TSUJIKAWA and AKITO TANAKA
    Anticancer Research April 2017, 37 (4) 1665-1676;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire